Company Profile

Itamar Medical™ is a medical device company and medical device manufacturer focused on leading the integration of Sleep Apnea management into the cardiac patient care pathway. As one of the leading home sleep testing companies in the US, the company has pioneered an innovative sleep apnea management program for patients and healthcare professionals.

Our core strategies include (i) the development, manufacturing and sales of the WatchPAT® diagnostic product line based on the biological PAT® signal acquired by the PAT® technology that was proven as a simple, comprehensive, reliable and scalable alternative to airflow and it enables point-of-deployment versatility; and (ii) Total Sleep Solutions – a product that includes a field support organization, partnerships, as well as core and supporting technologies that enable all physicians in general and Cardiologists, in particular, to provide a seamless and full continuum of care to Sleep Apnea patients as part of their care pathway.

In addition, the company has developed and is currently marketing the EndoPAT® system – an endothelial function assessment tool for risk classification used by clinicians, researchers and pharma companies to easily and reliably quantify and track arterial health.

WatchPAT

An innovative FDA-cleared home sleep apnea test for the diagnosis of sleep breathing disorders, specifically Sleep Apnea. It is a small wrist-mounted that allows home sleep apnea testing in the comfort of the patient’s own home.

Go to WatchPAT^® >

In addition, the medical device company has developed and is currently marketing the EndoPAT® system – an endothelial dysfunction assessment tool for risk classification used by clinicians, researchers, and pharma companies to easily and reliably quantify and track arterial health.

Partner Medical Device Companies

During the past few years, ZOLL Itamar has signed a number of strategic marketing agreements for its sleep apnea products, including agreements with Philips and Resmed in the US, and Philips Respironics and in Japan.

PAT^® Technology

Its proprietary technology enables the non-invasive recording, measurement and analysis of Peripheral Arterial Tonometry, or the PAT signal. The PAT signal measures changes in a patient’s pulsatile arterial volume, providing a “window” to the cardiovascular system and the sympathetic branch of the autonomic nervous system.

Vision

To be the leading global medical device company and medical device manufacturer providing complete sleep solutions for cardiac patients.

Mission

World Leader in Sleep Apnea Diagnosis & Management Solutions with a Focus on Additional Care Pathways.
On a Mission to Address the 80% Undiagnosed and Untreated through Digital Health Platform.

The corporate headquarters, R&D, and manufacturing for ZOLL Itamar are located in Israel. The company markets, services and supports its home sleep apnea testing products worldwide.